These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36059958)

  • 21. Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels.
    Pradhan A; Smith M; McGuire B; Evans C; Walwyn W
    Mol Pain; 2013 Mar; 9():8. PubMed ID: 23497324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the δ opioid receptor relieves cerebral ischemic injury in rats via EGFR transactivation.
    Chen M; Wu S; Shen B; Fan Q; Zhang R; Zhou Y; Zhang P; Wang L; Zhang L
    Life Sci; 2021 May; 273():119292. PubMed ID: 33667516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
    Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
    J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague-Dawley rats.
    Bausch SB; Garland JP; Yamada J
    Brain Res; 2005 May; 1045(1-2):38-44. PubMed ID: 15910761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.
    Nozaki C; Le Bourdonnec B; Reiss D; Windh RT; Little PJ; Dolle RE; Kieffer BL; Gavériaux-Ruff C
    J Pharmacol Exp Ther; 2012 Sep; 342(3):799-807. PubMed ID: 22700431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.
    Morinville A; Cahill CM; Kieffer B; Collier B; Beaudet A
    Pain; 2004 Jun; 109(3):266-273. PubMed ID: 15157687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ß-arrestin 2 germline knockout does not attenuate opioid respiratory depression.
    Bachmutsky I; Wei XP; Durand A; Yackle K
    Elife; 2021 May; 10():. PubMed ID: 34002697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons.
    Rowan MP; Szteyn K; Doyle AP; Gomez R; Henry MA; Jeske NA
    Mol Pain; 2014 Aug; 10():50. PubMed ID: 25085415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
    Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
    Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.
    Dripps IJ; Wang Q; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
    Psychopharmacology (Berl); 2017 Jan; 234(1):29-39. PubMed ID: 27624599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel G Protein-Biased Agonist at the
    Conibear AE; Asghar J; Hill R; Henderson G; Borbely E; Tekus V; Helyes Z; Palandri J; Bailey C; Starke I; von Mentzer B; Kendall D; Kelly E
    J Pharmacol Exp Ther; 2020 Feb; 372(2):224-236. PubMed ID: 31594792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonists.
    Nilson AN; Felsing DE; Wang P; Jain M; Zhou J; Allen J
    bioRxiv; 2024 Apr; ():. PubMed ID: 38659786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine 363 of the {delta}-opioid receptor is crucial for adopting distinct pathways to activate ERK1/2 in response to stimulation with different ligands.
    Xu C; Hong MH; Zhang LS; Hou YY; Wang YH; Wang FF; Chen YJ; Xu XJ; Chen J; Xie X; Ma L; Chi ZQ; Liu JG
    J Cell Sci; 2010 Dec; 123(Pt 24):4259-70. PubMed ID: 21098639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats.
    Jutkiewicz EM; Rice KC; Traynor JR; Woods JH
    Psychopharmacology (Berl); 2005 Nov; 182(4):588-96. PubMed ID: 16163520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
    Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
    PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand-Directed Signaling at the Delta Opioid Receptor.
    Vicente-Sanchez A; Pradhan AA
    Handb Exp Pharmacol; 2018; 247():73-85. PubMed ID: 28689302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice.
    Sakamoto K; Yamada D; Yamanaka N; Nishida M; Iio K; Nagase H; Saitoh A
    Brain Res; 2021 Apr; 1757():147297. PubMed ID: 33516811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
    Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
    J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.